Dynamic Product Labeling Technical

Evidence-Enhanced Product Labeling

(EPLs)

Jon DukeApril 15, 2014

What Are We Trying to Solve?

A Problem with Labeling• While considered the official source of drug

safety information– Labels are infrequently read by patient or providers– The evidence for a given ADR is often scant– They are one-size-fits-all and do not support

personalized decision-making

What Are We Trying to Solve?

A Problem with OHDSI• While we are developing superb methods and

brilliant tools to convey evidence on drug safety– Driving use of external tools requires significant

activation energy – Awareness of the evidence being generated by OHDSI

may diffuse slowly even to those who would be extremely interested (e.g., drug knowledge vendors)

– Users will generally need to know what they are looking for (e.g., what drug-outcome pairs)

4

The EPL Big Picture

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~

~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~ ~~ ~~

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~

~~ ~~~ ~~ ~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~

~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~ ~~ ~~

~~~ ~~ ~~ ~~

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~

StructuredProduct Label

EnhancedProduct Label

Evidence-Enhanced Product Labeling

• EPL is a platform for injecting approved product labeling with evidence from external sources

• Evidence may manifest as– visual emphasis / de-emphasis of label content– on-demand display of data and visualizations

• EPL is a trojan horse for getting people to see the incredible work of OHDSI while using a standard reference

Enhanced Product Labeling:Framework vs App

• EPL is fundamentally a framework that can work with any web application

• Two Reference Apps– Embedding of HOMER-like content within SPL

(DOI_HOI evidence base)– Embedding of PLATO-like content within SPL

(requires mechanism to capture patient data- manual inputs, CCD, blue button, etc)

JSLibrary

OHDSIAPIs

Other Evidence Sources

OHDSIKB

OHDSIPLATO

ServicesSPL

Potential OHDSI KB Content

9

What’s in an SPL?Part 1: XML (the content)

XML/XSL/CSS HTML

10

What’s in an SPL?Part 2: XSLT (the format)

11

What’s in an SPL?Part 3: CSS (the style)

12

What’s in an SPL?Roll them together HTML

13

What’s in an SPL?HTML

14

What’s in an SPL?HTML

EPL Javascript

SPLXML/XSL/CSS HTML

EPL / OHDSIAPIs

Other Evidence Sources

OHDSIKB

OHDSIPLATO

Services

Web App

EPL.js

Structured Product Label

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~

~~ ~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~

Tell me all the known ADRs for this drug

From SPL to EPL

EPL / OHDSIAPIs

EPL / OHDSIAPIs

Web App

EPL.js

Structured Product Label

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~

~~ ~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~

From SPL to EPL

Web App

EPL.js

From SPL to EPL

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~

~~ ~~ ~~~

Web App

EPL.js

From SPL to EPL

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~

~~ ~~ ~~~

Web App

EPL.js

From SPL to EPL

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~

~~ ~~ ~~~

Web App

EPL.js

From SPL to EPL

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~

~~ ~~ ~~~

Web App

EPL.js

Tell me the specific evidence for this HOIDOI_HOI_id=234515

Detail On-Demand

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~ ~~~~~ ~~ ~~ ~~ ~~ ~~

~~ ~~ ~~~

EPL / OHDSIAPIs

EPL / OHDSIAPIs

Web App

EPL.js

Structured Product Label

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~

~~ ~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~

~~~ ~~ ~~~

From SPL to EPL

Adverse Reactions~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~

~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~

~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~

~~~~~ ~~ ~~ ~~ns

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~ ~~~ ~~ ~ ~~ ~~~ ~~ ~~~ ~~

~~~ ~~ ~~ ~~

Advanced Jquery Tooltips supportAJAX calls, visualzations, full HTML5

25

Example EPL Prototype

26

Example EPL Prototype

27

Final Thoughts

• Evidence-enhancement not limited to SPLs, could be applied to SPCs or any other web content with identifiable drugs and outcomes

• Designed to be flexible in terms of novel evidence sources and presentation layers

• Will develop in parallel with OHDSI KB and APIs

28

Thanks!

Questions?